Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vascularized Composite Bladder Allograft Transplantation: a Phase 0 (First-in-human) Study for Deceased Donor Bladder or Combined Kidney-bladder Transplantation

NCT06337942 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT06337942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06337942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vascularized Composite Bladder Allograft Transplantation: a Phase 0 (First-in-human) Study for Deceased Donor Bladder or Combined Kidney-bladder Transplantation
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2025
Completion date
January 31, 2028
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder disease, bladder, neurogenic, kidney failure